Public Policy Projects

Public Policy Projects

Public Policy Projects (PPP) is a research organization that provides useful insights and solutions in various fields such as healthcare, social services, life sciences, and environmental issues like net-zero goals and climate change.

National
English
Research Company/Group

Outlet metrics

Domain Authority
39
Ranking

Global

#3867747

United Kingdom

#305103

Category

N/A

Traffic sources
Monthly visitors

Articles

  • Nov 13, 2024 | publicpolicyprojects.com | Gabriel Blaazer

    Medicines shortages are a stark and indiscriminate barrier to patient access to medicines. Patients are rationing their medicines and time pharmacists waste on sourcing medicines is time lost from the delivery of pharmacy services. There is variation in the uptake and deployment of NICE-approved medicines across integrated care systems, interfering with patients’ legal right to access these medicines, as outlined in the NHS constitution.

  • Aug 9, 2024 | publicpolicyprojects.com | Gabriel Blaazer

    The new programme is designed to embed patient safety as a core priority across national and local health systems PPP and Patient Safety Learning will develop the programme with a focus on how technology can enable patient centred patient safety A new editorial board will be established, chaired by Helen Hughes, where key stakeholders, including industry partners and patient leaders, will set editorial direction Global enterprise software company, RLDatix, is the first programme partner and...

  • Jun 24, 2024 | publicpolicyprojects.com | Gabriel Blaazer

    The UK has been at the forefront of AI development, with the government investing significant sums. However, despite strong R&D across the country, the NHS is not always benefitting from advancements as there are barriers to scaling innovation. Barriers include workforce capability, funding to implement technology, IT resource capability and estates.

  • Jun 21, 2024 | publicpolicyprojects.com | Samantha Semmeling

    Medicines are the second highest cost to the NHS after staffing and present an untapped opportunity to meet ICS strategic priorities and deliver better value for money. Outcomes-centred contractual frameworks and greater stakeholder collaboration between the NHS and industry is required to unlock value-based medicines optimisation.

  • Jun 3, 2024 | publicpolicyprojects.com | Jenny Jenkins

    Announcing the news, Managing Director Lee Davies said:“Our acquisition of PMF builds on the PPP Global Genomics network and positions PPP at the heart of key developments in personalised medicine and its implications for health and life sciences.

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

Email Patterns

Contact Forms

Contact Form

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations